SD Biosensor, Inc (KRX:137310)
South Korea · Delayed Price · Currency is KRW 9,930.00
+50.00 (0.51%)
At close: Jul 25, 2025, 3:30 PM KST
SD Biosensor Revenue
SD Biosensor had revenue of 185.33B KRW in the quarter ending March 31, 2025, with 5.07% growth. This brings the company's revenue in the last twelve months to 703.51B, up 8.29% year-over-year. In the year 2024, SD Biosensor had annual revenue of 694.57B with 5.93% growth.
Revenue (ttm)
703.51B
Revenue Growth
+8.29%
P/S Ratio
1.69
Revenue / Employee
1.22B
Employees
576
Market Cap
1,187.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 694.57B | 38.90B | 5.93% |
| Dec 31, 2023 | 655.68B | -2,276.32B | -77.64% |
| Dec 31, 2022 | 2,932.00B | 2.04B | 0.07% |
| Dec 31, 2021 | 2,929.96B | 1,243.80B | 73.76% |
| Dec 31, 2020 | 1,686.16B | 1,613.20B | 2,211.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| Peptron | 4.30B |
| HLB Co., Ltd. | 74.64B |
| PharmaResearch | 392.31B |